Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An observational, retrospective, multicenter study to assess the efficacy of fingolimod in clinical practice in patients with relapsing-remitting multiple sclerosis

Trial Profile

An observational, retrospective, multicenter study to assess the efficacy of fingolimod in clinical practice in patients with relapsing-remitting multiple sclerosis

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Jul 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fingolimod (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms NEXT
  • Most Recent Events

    • 27 Jun 2017 Results (n=988) of a pooled analysis of two observational retrospective studies MS SECOND LINE GATE and MS NEXT assessing basal characteristics and effectiveness of fingolimod, presented at the 3rd Congress of the European Academy of Neurology
    • 28 Apr 2017 Results (n=988) of a pooled analysis of two observational retrospective studies (MS SECOND LINE GATE and MS NEXT) assessing safety and tolerability of fingolimod in Spanish clinical practice, presented at the 69th Annual Meeting of the American Academy of Neurology
    • 28 Apr 2017 Results of pooled analysis of two observational retrospective studies (MS SECOND LINE GATE and MS NEXT) presented at the 69th Annual Meeting of the American Academy of Neurology
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top